Can Buspirone Cause Hypertension?
Yes, buspirone can cause hypertension, particularly when combined with MAOIs, and there are documented cases of severe hypertension with buspirone monotherapy, though this is uncommon.
FDA-Labeled Warnings
The FDA drug label explicitly warns that buspirone combined with MAOIs may cause elevated blood pressure 1. The label states: "There have been reports of the occurrence of elevated blood pressure when buspirone hydrochloride has been added to a regimen including an MAOI" 1. This is a black box-level concern requiring absolute avoidance of this combination.
Additionally, the FDA label identifies hypertension as an infrequent adverse event (occurring in 1/100 to 1/1,000 patients) in controlled clinical trials 1. While not among the most common side effects, it is a recognized cardiovascular adverse reaction.
Clinical Evidence of Hypertensive Risk
Severe Hypertension Cases
A 2025 case report documented severe, treatment-resistant hypertension directly caused by buspirone monotherapy 2. A 55-year-old woman developed significantly elevated blood pressure unresponsive to standard treatments after starting buspirone. Investigation revealed elevated plasma and urinary catecholamines mimicking pheochromocytoma. Discontinuation of buspirone normalized catecholamine levels and blood pressure control 2.
Mechanism of Hypertensive Effect
The hypertensive mechanism involves:
- Sympathetic nervous system activation with increased catecholamine release 2, 3
- Direct alpha-1 adrenergic receptor stimulation causing vasoconstriction 3
- Elevated norepinephrine and epinephrine levels documented in both stressed and non-stressed states 4
Importantly, animal studies demonstrate that buspirone's pressor effect occurs through dual mechanisms: sympathoexcitation AND direct vascular alpha-1 receptor activation, particularly in hypovolemic states 3.
Clinical Context and Monitoring
When Hypertension Risk is Highest:
- Combination with MAOIs (contraindicated) 1
- Combination with other serotonergic agents (linezolid, SSRIs, triptans) - can cause serotonin syndrome with hypertension as a feature 1, 5
- Patients with pre-existing cardiovascular instability 2
Monitoring Recommendations:
- Measure baseline blood pressure before initiating buspirone
- Monitor blood pressure during dose titration, especially in the first 2-4 weeks
- If unexplained hypertension develops, consider buspirone as a potential cause
- If blood pressure becomes severely elevated and refractory to treatment, discontinue buspirone and evaluate for elevated catecholamines 2
Important Caveats
Paradoxical finding: One animal study (2023) showed buspirone actually lowered blood pressure in spontaneously hypertensive rats through PPARδ-dependent mechanisms 6. However, this contradicts human case reports and FDA labeling, and should not influence clinical decision-making in humans.
The most common cardiovascular effect in clinical trials was actually tachycardia/palpitations (1% incidence), not hypertension 1. However, the severity of hypertension when it occurs—as demonstrated by the 2025 case report—warrants vigilance.
Bottom Line for Practice
While hypertension is not a frequent adverse effect of buspirone monotherapy, it is:
- Documented and potentially severe when it occurs 2
- Absolutely contraindicated with MAOIs due to hypertensive crisis risk 1
- Mechanistically plausible through catecholamine elevation and direct vascular effects 3, 4
- Reversible upon discontinuation 2
Monitor blood pressure in patients starting buspirone, particularly those with cardiovascular risk factors or taking other serotonergic medications.